[Hiring] Senior Manager, Regional Access @Revolution Medicines

Role Description

In this role you will drive the execution of regional and local market access priorities within the national market access strategy, identifying and prioritizing barriers to timely and sustainable patient access. The role will be responsible for providing hands-on support in executing key launch activities across Germany supporting country-level regional and local market access tactics and initiatives to secure reimbursement of Revolution Medicines’ assets.

In close cooperation with the sales, marketing, government affairs, and medical departments and in line with the overall commercial business strategy, you will have an instrumental role in the development and execution of market access solutions. This will involve detailed and strategic involvement of various internal and external stakeholders, including:

• Hospitals
• Office-based oncologists
• Pharmacies
• Health insurances
• Medical associations
• Policy makers

Key Responsibilities

• Secure listing in hospital pharmacy lists for Revolution Medicines’ assets once available across Germany, identifying organizational hurdles that might hinder broad adaptation in existing treatment algorithms.
• Identify market specific needs of prescribers, pharmaceutical decision makers and health policy stakeholders and develop tactics to address evolving market access barriers.
• Identify access barriers and developing/recommending regional or local approaches and tactics within the established market-access strategy to enable patient-access.
• Establish and maintain a network amongst opinion leaders, health insurances, physicians’ associations, and health policy makers.
• Serve as one of the primary contact points for various market access stakeholder groups, including health insurances (incl. MDK), pharmacies, and hospital administrators.
• Monitor, collect and inform internal stakeholders with insights on emerging changes in the pharmaceutical policy, pricing, and market access reimbursement framework relevant in the context of Revolution Medicines’ assets.
• Translate regional insights into actionable recommendations for the regional and national market access team to inform launch and lifecycle planning.
• Position and represent Revolution Medicines and its assets in the best possible way towards all relevant healthcare bodies and stakeholders in Germany.
• Jointly with the Regional Access team initiate and organize regional/local events and projects to support reimbursement activities.
• Provide internal and external explanations and training materials regarding market access topics for all relevant stakeholder groups.
• Partner with Sales, Medical and other relevant functions to address regional patient-access barriers, taking ownership of agreed access-related initiatives and providing expertise on reimbursement matters.

Qualifications

• Bachelor’s degree required; advanced degree in Pharmacy, Health Economics, Public Health, Life Sciences, or Business preferred (e.g., PharmD, PhD, MBA).
• 6+ years of experience in a Regional Market Access role within the pharmaceutical or biopharma industry.
• Extensive experience in working with statutory health insurance companies in Germany, as well as with physicians’ associations, MDK (“Medizinischer Dienst”), and other stakeholders.
• Extensive knowledge of existing regulations in the German pharmaceutical healthcare system.
• Proven successful interaction with relevant stakeholders within the self-governing bodies in Germany.

Requirements

• Knowledge of the legal pricing framework, post-AMNOG system-imminent access hurdles, dispensing of pharmaceuticals, taxation and reimbursement framework.
• Understanding of (re-) importation of pharmaceuticals and federal/regional contracts on dispensation of pharmaceuticals.

Company Description

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.